NASDAQ:RXST RxSight (RXST) Stock Price, News & Analysis $44.50 -0.80 (-1.77%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$43.64▼$46.3950-Day Range$44.50▼$62.6452-Week Range$20.66▼$66.54Volume695,186 shsAverage Volume471,010 shsMarket Capitalization$1.65 billionP/E RatioN/ADividend YieldN/APrice Target$65.14 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get RxSight alerts: Email Address RxSight MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside46.4% Upside$65.14 Price TargetShort InterestBearish5.38% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.98Based on 8 Articles This WeekInsider TradingSelling Shares$4.43 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.75) to ($0.36) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.44 out of 5 starsMedical Sector316th out of 936 stocksOphthalmic Goods Industry3rd out of 7 stocks 4.5 Analyst's Opinion Consensus RatingRxSight has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageRxSight has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about RxSight's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.38% of the float of RxSight has been sold short.Short Interest Ratio / Days to CoverRxSight has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in RxSight has recently increased by 7.57%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldRxSight does not currently pay a dividend.Dividend GrowthRxSight does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RXST. Previous Next 3.9 News and Social Media Coverage News SentimentRxSight has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for RxSight this week, compared to 3 articles on an average week.Search Interest6 people have searched for RXST on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat Follows7 people have added RxSight to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, RxSight insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,425,250.00 in company stock.Percentage Held by InsidersOnly 9.36% of the stock of RxSight is held by insiders.Percentage Held by Institutions78.78% of the stock of RxSight is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about RxSight's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for RxSight are expected to grow in the coming year, from ($0.75) to ($0.36) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RxSight is -35.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of RxSight is -35.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRxSight has a P/B Ratio of 9.96. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about RxSight's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad American Hartford Gold GroupDave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE About RxSight Stock (NASDAQ:RXST)RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.Read More RXST Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RXST Stock News HeadlinesJuly 3, 2024 | insidertrades.comInsider Selling: RxSight, Inc. (NASDAQ:RXST) CFO Sells 10,000 Shares of StockJuly 23 at 7:49 PM | ca.finance.yahoo.comRXST Sep 2024 35.000 putJuly 26, 2024 | Darwin (Ad)Top Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.July 22, 2024 | globenewswire.comRxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024July 21, 2024 | americanbankingnews.comRxSight (NASDAQ:RXST) Trading 3.6% Higher July 16, 2024 | americanbankingnews.comRxSight, Inc. (NASDAQ:RXST) Sees Significant Increase in Short InterestJuly 10, 2024 | seekingalpha.comRxSight: Great Business Model, Stretched ValuationsJune 5, 2024 | globenewswire.comRxSight, Inc. To Participate in the Truist Securities Medtech ConferenceJuly 26, 2024 | Darwin (Ad)Top Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.May 13, 2024 | finance.yahoo.comRxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesMay 13, 2024 | globenewswire.comRxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesMay 10, 2024 | finance.yahoo.comRxSight, Inc. (NASDAQ:RXST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$72.75May 9, 2024 | msn.comWhy RxSight (RXST) Shares Are FallingMay 9, 2024 | finance.yahoo.comRxSight First Quarter 2024 Earnings: Beats ExpectationsMay 9, 2024 | msn.comRxSight price raises equity at $56 per shareMay 8, 2024 | globenewswire.comRxSight, Inc. Announces Pricing of Public Offering of Common StockMay 8, 2024 | markets.businessinsider.comRxSight’s Strong Q1 Performance and Market Expansion Justify Buy RatingMay 7, 2024 | markets.businessinsider.comRxSight Outperforms with Strong Q1 Results and Raised Guidance: Buy Rating AffirmedSee More Headlines Receive RXST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/06/2024Today7/26/2024Next Earnings (Confirmed)8/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Ophthalmic goods Sub-IndustryN/A Current SymbolNASDAQ:RXST CUSIPN/A CIK1111485 Webwww.rxsight.com Phone949-521-7830FaxN/AEmployees374Year FoundedN/APrice Target and Rating Average Stock Price Target$65.14 High Stock Price Target$75.00 Low Stock Price Target$36.00 Potential Upside/Downside+45.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($1.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-48,610,000.00 Net Margins-44.01% Pretax Margin-43.98% Return on Equity-27.68% Return on Assets-23.96% Debt Debt-to-Equity RatioN/A Current Ratio9.20 Quick Ratio8.18 Sales & Book Value Annual Sales$89.08 million Price / Sales18.61 Cash FlowN/A Price / Cash FlowN/A Book Value$4.47 per share Price / Book10.02Miscellaneous Outstanding Shares36,990,000Free Float33,526,000Market Cap$1.66 billion OptionableOptionable Beta1.20 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesDr. Ronald M. Kurtz M.D. (Age 61)President, CEO & Director Comp: $1.21MMs. Shelley B. Thunen (Age 70)Chief Financial Officer Comp: $762.22kDr. Ilya Goldshleger Ph.D. (Age 49)Chief Operating Officer Comp: $761.46kMr. Eric J. Weinberg (Age 63)Chief Commercial Officer Comp: $762.74kMs. Rebecca WillistonVice President of Accounting & FinanceMr. Matt Haller Ph.D.Chief Technology OfficerMr. Oliver MoravcevicVice President of Investor RelationsMr. Roy FreemanVice President of MarketingMs. Caroline VaughnVice President of Human ResourcesMr. Scott GainesSenior VP of Commercial Operations & Business ProcessMore ExecutivesKey CompetitorsBausch Health CompaniesNYSE:BHCClearPoint NeuroNASDAQ:CLPTEdap TmsNASDAQ:EDAPNeuroneticsNASDAQ:STIMApyx MedicalNASDAQ:APYXView All CompetitorsInsiders & InstitutionsAllspring Global Investments Holdings LLCSold 12,412 shares on 7/26/2024Ownership: 0.473%Bank of New York Mellon CorpBought 17,368 shares on 7/26/2024Ownership: 0.323%Legato Capital Management LLCBought 9,486 shares on 7/26/2024Ownership: 0.081%Bailard Inc.Bought 4,100 shares on 7/26/2024Ownership: 0.011%RiverPark Advisors LLCBought 297 shares on 7/26/2024Ownership: 0.009%View All Insider TransactionsView All Institutional Transactions RXST Stock Analysis - Frequently Asked Questions How have RXST shares performed this year? RxSight's stock was trading at $40.32 at the beginning of the year. Since then, RXST stock has increased by 10.4% and is now trading at $44.50. View the best growth stocks for 2024 here. How were RxSight's earnings last quarter? RxSight, Inc. (NASDAQ:RXST) released its quarterly earnings data on Monday, May, 6th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.17) by $0.08. RxSight's revenue for the quarter was up 68.7% on a year-over-year basis. When did RxSight IPO? RxSight (RXST) raised $125 million in an IPO on Friday, July 30th 2021. The company issued 7,350,000 shares at $16.00-$18.00 per share. Who are RxSight's major shareholders? Top institutional investors of RxSight include Baillie Gifford & Co. (0.97%), Allspring Global Investments Holdings LLC (0.47%), M&G Plc (0.43%) and Bank of New York Mellon Corp (0.32%). Insiders that own company stock include Ronald M Md Kurtz, Eric Weinberg, Julie Andrews, Robert Keith Warner, Ilya Goldshleger, William J Phd Link, Shelley B Thunen, Jesse Anderson Corley and Shweta Maniar. View institutional ownership trends. How do I buy shares of RxSight? Shares of RXST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:RXST) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RxSight, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RxSight With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RXST Stock Alerts